CLINICAL TRIALS PROFILE FOR SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER

All Clinical Trials for Sodium Lactate 0.167 Molar In Plastic Container

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	Diabetes Australia	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	Hoffmann-La Roche	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	National Health and Medical Research Council, Australia	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	Baker Heart Research Institute	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00279617 ↗	Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks	Completed	UCB Pharma	Phase 3	2006-01-01	The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
NCT00279617 ↗	Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks	Completed	University of Cincinnati	Phase 3	2006-01-01	The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
NCT00279617 ↗	Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks	Completed	Lindner Center of HOPE	Phase 3	2006-01-01	The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.

Clinical Trial Conditions for Sodium Lactate 0.167 Molar In Plastic Container

Condition Name

Condition Name for Sodium Lactate 0.167 Molar In Plastic Container
Intervention	Trials
Septic Shock	3
Hyperlactatemia	3
Lactate	3
Healthy	2

Condition MeSH

Condition MeSH for Sodium Lactate 0.167 Molar In Plastic Container
Intervention	Trials
Shock	8
Wounds and Injuries	5
Brain Injuries	5
Shock, Septic	4

Clinical Trial Locations for Sodium Lactate 0.167 Molar In Plastic Container

Trials by Country

Trials by Country for Sodium Lactate 0.167 Molar In Plastic Container
Location	Trials
United States	14
France	6
Indonesia	5
Moldova, Republic of	4
Egypt	4

Trials by US State

Trials by US State for Sodium Lactate 0.167 Molar In Plastic Container
Location	Trials
California	3
Utah	1
Pennsylvania	1
New Mexico	1
Florida	1

Clinical Trial Progress for Sodium Lactate 0.167 Molar In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Sodium Lactate 0.167 Molar In Plastic Container
Clinical Trial Phase	Trials
Phase 4	23
Phase 3	15
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for Sodium Lactate 0.167 Molar In Plastic Container
Clinical Trial Phase	Trials
Completed	34
Not yet recruiting	14
Recruiting	11

Clinical Trial Sponsors for Sodium Lactate 0.167 Molar In Plastic Container

Sponsor Name

Sponsor Name for Sodium Lactate 0.167 Molar In Plastic Container
Sponsor	Trials
Innogene Kalbiotech Pte. Ltd	5
Yuria-Pharm	4
Institut d'Anesthesiologie des Alpes Maritimes	3

Sponsor Type

Sponsor Type for Sodium Lactate 0.167 Molar In Plastic Container
Sponsor	Trials
Other	85
Industry	20
NIH	1